- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | AstraZeneca to Invest in Shanghai Innovation Center | ||
| Fr | Novartis Agrees to Acquire Pan-Mutant-Selective PI3KA Inhibitor from Synnovation Therapeutics | ||
| Do | Atossa Therapeutics Appoints Two New Medical Directors in Breast Oncology and Rare Diseases | ||
| Do | SK pharmteco Makes $100M Funding Commitment to Support Viral Vector Business | ||
| Do | Roche Enters Academic-Industry Collaboration with NIPER Raebareli in India | ||
| Do | Evotec Receives Milestone Payment from BMS for Protein Degradation Collaboration | ||
| Do | Esteve CDMO to Add New Production Unit in Celr | ||
| Do | Phlow Corp. Taps Dawn Von Rohr as Chief Operating Officer | ||
| Do | Harbour BioMed Appoints Dr. Jenny Xie as Chief Scientific Officer | ||
| Do | LGM Pharma Commits an Additional $9M to its Texas and Colorado Facilities | ||
| Mi | Kupando Secures €10M More in Series A Funding for Oncology, Infectious Disease Programs | ||
| Mi | Excalipoint Therapeutics Launches, Will Develop Next-Gen T-Cell Engagers | ||
| Mi | Samsung Bioepis, Sandoz Ink Licensing Agreement for Up to Five Biosimilars | ||
| Mi | Oxford Biomedica Signs Licensing Deal with Australia's VVMF | ||
| Mi | Green Elephant Biotech Introduces Archimedes One for Cell Therapy Manufacturing | ||
| Mi | IsomAb Appoints Dr. Philip Brainin as Chief Executive Officer | ||
| Mi | Aptamer Group Introduces Targeted Radiopharmaceutical Program | ||
| Di | Terumo BCT, Taiwan Bio to Advance Treg Manufacturing onto Automated Platform | ||
| Di | Axplora Expands Farmabios Site in Gropello Cairoli | ||
| Di | SK pharmteco Completes Regulatory Inspection of La Porte Facility | ||
| Di | Alchemab Appoints Ulrich Wendt as Chief Business Officer | ||
| Di | Alebund Pharmaceuticals, R1 Therapeutics Partner to Advance AP306 Outside China | ||
| Mo | Piramal Pharma Solutions Completes 1,500th ADC Batch at Grangemouth Facility | ||
| Mo | Sentynl to License Investigational Molecule from PRG S&T for Progeria Treatment | ||
| Mo | Celltrion's Avtozma Available in Subcutaneous Formulation for US Patients |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.